InvestorsHub Logo
icon url

georgejjl

12/29/14 8:15 AM

#9 RE: marcusl2 #8

Marcus,

I am glad to see you are posting here.

Yes, Oxford BioMedica has a lot of potential.

I am especially excited about the CAR 5T4 for various solid tumors. Can you imagine a CAR treatment similar to Novartis's CTL-019 but for various solid tumors?

Good luck and GOD bless,

George